- Home
- MAIA vs ETON Comparison
MAIA vs ETON Comparison
Compare MAIA & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- ETON
- Stock Information
- Founded
- MAIA 2018
- ETON 2017
- Country
- MAIA United States
- ETON United States
- Employees
- MAIA N/A
- ETON N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- MAIA Health Care
- ETON Health Care
- Exchange
- MAIA Nasdaq
- ETON Nasdaq
- Market Cap
- MAIA 46.7M
- ETON 428.5M
- IPO Year
- MAIA 2022
- ETON 2018
- Fundamental
- Price
- MAIA $1.90
- ETON $14.48
- Analyst Decision
- MAIA
- ETON Strong Buy
- Analyst Count
- MAIA 0
- ETON 3
- Target Price
- MAIA N/A
- ETON $29.67
- AVG Volume (30 Days)
- MAIA 540.7K
- ETON 611.7K
- Earning Date
- MAIA 08-08-2025
- ETON 08-07-2025
- Dividend Yield
- MAIA N/A
- ETON N/A
- EPS Growth
- MAIA N/A
- ETON N/A
- EPS
- MAIA N/A
- ETON N/A
- Revenue
- MAIA N/A
- ETON $48,327,000.00
- Revenue This Year
- MAIA N/A
- ETON $103.21
- Revenue Next Year
- MAIA N/A
- ETON $51.34
- P/E Ratio
- MAIA N/A
- ETON N/A
- Revenue Growth
- MAIA N/A
- ETON 40.88
- 52 Week Low
- MAIA $1.40
- ETON $3.22
- 52 Week High
- MAIA $4.24
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- MAIA 56.86
- ETON 42.19
- Support Level
- MAIA $1.60
- ETON $13.51
- Resistance Level
- MAIA $2.03
- ETON $14.61
- Average True Range (ATR)
- MAIA 0.12
- ETON 0.79
- MACD
- MAIA 0.02
- ETON 0.07
- Stochastic Oscillator
- MAIA 69.77
- ETON 60.70
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.